Skip to content

A prospective study of fluorescent laparoscopic counterstaining-guided for hepatic hemangioma resection

A prospective study of fluorescent laparoscopic counterstaining-guided for hepatic hemangioma resection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100231
Enrollment
Unknown
Registered
2025-04-07
Start date
2025-04-25
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic hemangioma

Interventions

Control group:Laparoscopic operation
Test group:Fluorescent laparoscopic reverse staining

Sponsors

Yijishan Hospital of Wannan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.The imaging examination confirmed it as a hepatic hemangioma; 2. imaging examination found single or multiple tumors, in which the tumor diameter = 5 cm and the corresponding abdominal discomfort symptoms or accompanied by rapid tumor enlargement (annual volume increase >= 2 cm); 3.Aged between 15 and 80 years old; 4. The patient have good cardiopulmonary function and can tolerate laparoscopic surgery; 5.The liver function is good, at Child A and Child B levels; 6. Voluntary participation and signature of informed consent;

Exclusion criteria

Exclusion criteria: 1. The diagnosis of hepatic hemangioma is unclear; 2. The diameter of hepatic hemangioma is less than 5 cm; 3. The liver function is at Child C stage; 4. Unable to tolerate laparoscopic surgery; 5. Refused to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Operation time;Intraoperative blood loss;Whether transfusion is necessary and the amount of blood transfusion required;Conversion to laparotomy;Mode and frequency of hepatic portal occlusion;Age;Gender;Hepatic hemangioma size;Location of hepatic hemangioma;Postoperative hospital stay;Postoperative ventilation time;Postoperative hemorrhage;Postoperative bile leakage;Liver function;Complete blood count;

Secondary

MeasureTime frame
BMI;Complications of underlying diseases;History of abdominal surgery;Other postoperative complications (such as pneumonia, atelectasis, abdominal infection, lower extremity thrombosis, etc.);Total hospitalization expenses;

Countries

CHINA

Contacts

Public ContactYu Yuanlin

Yijishan Hospital of Wannan Medical College

yuyuanlin880610@163.com+86 158 0553 4032

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026